Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue Health Condition 2: M958- Other specified acquired deformities of musculoskeletal system
Conditions
Interventions
Intervention1: DEXMEDETOMIDINE WITH ROPIVACAINE: IN THIS GROUP PATIENTS WILL RECEIVE 30ml OF 0.5% ROPIVACAINE CONTAINING 1mcg/kg DEXMEDITOMIDINE IN USG GUIDED SUPRACLAVICULAR BRACHIAL PLEXUX BLOCK.PAT
Sponsors
Dr Umesh N P
Dr Arunkumaran D
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of both sexes aged =18 yrs. 2.Patients undergoing elective upper limb surgeries. 3.ASA-PS I and II patients. 4.Patients who are willing to participate in the study with informed consent.
Exclusion criteria
Exclusion criteria: 1.Infection at site of injection. 2.Patients who have peripheral neuropathy. 3.Presence of 1st,2nd and 3rd degree heart block. 4.Patients who are pregnant. 5.Patients who have coagulopathies. 6.Patients who have allergy or hypersensitivity to local anaesthetic drugs.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1.To compare the sedation during intraoperative period. 2.To compare the duration of analgesia in post operative period. 3.Side effects such as vomiting,pruritus,local anaesthetic associated systemic toxicity.Timepoint: 24 hrs | — |
Primary
| Measure | Time frame |
|---|---|
| To compare the onset and duration of motor and sensory block between dexmedetomidine and dexamethasone as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus block.Timepoint: 24 HOURS | — |
Countries
India
Contacts
Public ContactDr Umesh N P
Mandya institute of medical sciences
Outcome results
None listed